These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2625827)

  • 21. [Local recurrence after organ saving kidney tumor surgery].
    Brkovic D; Riedasch G; Waldherr R; Röhl L; Staehler G
    Urologe A; 1994 Mar; 33(2):104-9. PubMed ID: 8178403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in peritumoral pseudocapsule characteristics according to clinicopathological factors in clinical T1a renal tumors.
    Kim M; Choi WS; Jeong CW; Ku JH; Kim HH; Moon KC; Kwak C
    Int J Clin Exp Pathol; 2015; 8(9):11323-31. PubMed ID: 26617856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histological analysis of the kidney tumor-parenchyma interface.
    Azhar RA; de Castro Abreu AL; Broxham E; Sherrod A; Ma Y; Cai J; Gill TS; Desai M; Gill IS
    J Urol; 2015 Feb; 193(2):415-22. PubMed ID: 25111913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
    Blute ML; Itano NB; Cheville JC; Weaver AL; Lohse CM; Zincke H
    J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal cell carcinoma: evaluation of the 1997 TNM system and recommendations for follow-up after surgery.
    Gofrit ON; Shapiro A; Kovalski N; Landau EH; Shenfeld OZ; Pode D
    Eur Urol; 2001 Jun; 39(6):669-74; discussion 675. PubMed ID: 11464056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conservative surgical treatment of renal cell carcinoma. The University of Miami experience.
    Block NL; Ciancio G
    J Fla Med Assoc; 1995 Sep; 82(9):607-11. PubMed ID: 7595342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nephron-sparing surgery for renal cell carcinoma with venous involvement.
    Angermeier KW; Novick AC; Streem SB; Montie JE
    J Urol; 1990 Dec; 144(6):1352-5. PubMed ID: 2231924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Organ-preserving surgery for renal cell carcinoma in patients with a solitary kidney or bilateral tumors.
    Hubmer G; Petritsch PH
    Semin Surg Oncol; 1988; 4(2):133-6. PubMed ID: 3393775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of tumor recurrence and guidelines for followup after nephron sparing surgery for sporadic renal cell carcinoma.
    Hafez KS; Novick AC; Campbell SC
    J Urol; 1997 Jun; 157(6):2067-70. PubMed ID: 9146581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Multicentricity and concomitant tumors in renal cell carcinoma: analysis by serial section of resected kidneys].
    Saiki S; Kinouchi T; Meguro N; Maeda O; Kuroda M; Usami M; Kotake T
    Hinyokika Kiyo; 1995 Sep; 41(9):725-9. PubMed ID: 7484540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nephron-sparing surgery--strategies for partial nephrectomy in renal cell carcinoma.
    Ljungberg B
    Scand J Surg; 2004; 93(2):126-31. PubMed ID: 15285564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of small solitary unilateral renal cell carcinomas: impact of central versus peripheral tumor location.
    Hafez KS; Novick AC; Butler BP
    J Urol; 1998 Apr; 159(4):1156-60. PubMed ID: 9507821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.
    Lerner SE; Hawkins CA; Blute ML; Grabner A; Wollan PC; Eickholt JT; Zincke H
    J Urol; 1996 Jun; 155(6):1868-73. PubMed ID: 8618276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anatomic comparison of traditional and enucleation partial nephrectomy specimens.
    Calaway AC; Gondim DD; Flack CK; Jacob JM; Idrees MT; Boris RS
    Urol Oncol; 2017 May; 35(5):221-226. PubMed ID: 28153421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Surgical treatment of renal cell carcinoma].
    Kakizoe T
    Gan To Kagaku Ryoho; 1994 Jan; 21(1):17-22. PubMed ID: 8291911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of high nuclear grade in patients with pathologic T1a renal cell carcinoma.
    Suzuki K; Mizuno R; Mikami S; Tanaka N; Kanao K; Kikuchi E; Miyajima A; Nakagawa K; Oya M
    Jpn J Clin Oncol; 2012 Sep; 42(9):831-5. PubMed ID: 22811408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional and oncological outcomes of partial nephrectomy of solitary kidneys.
    La Rochelle J; Shuch B; Riggs S; Liang LJ; Saadat A; Kabbinavar F; Pantuck A; Belldegrun A
    J Urol; 2009 May; 181(5):2037-42; discussion 2043. PubMed ID: 19298974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nephron-sparing surgery for localized renal cell carcinoma with a normal contralateral kidney: a European three-center experience.
    Delakas D; Karyotis I; Daskalopoulos G; Terhorst B; Lymberopoulos S; Cranidis A
    Urology; 2002 Dec; 60(6):998-1002. PubMed ID: 12475657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis.
    Gorin MA; Ball MW; Pierorazio PM; Tanagho YS; Bhayani SB; Kaouk JH; Rogers CG; Stifelman MD; Khalifeh A; Kumar R; Sivarajan G; Allaf ME
    J Urol; 2013 Nov; 190(5):1907-11. PubMed ID: 23764083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.